Works matching DE "CYTOKINE release syndrome"
Results: 2484
SHIP‐1 Differentially Regulates IgE‐Induced IL‐10 and Antiviral Responses in Human Monocytes.
- Published in:
- European Journal of Immunology, 2025, v. 55, n. 2, p. 1, doi. 10.1002/eji.202451065
- By:
- Publication type:
- Article
An Atypical Presentation of Cytokine Release Syndrome With Signs of Arthritis During Treatment With Teplizumab in a Pediatric Patient.
- Published in:
- 2025
- By:
- Publication type:
- Letter
TLR4 Inhibition Attenuated LPS‐Induced Proinflammatory Signaling and Cytokine Release in Mouse Hearts and Cardiomyocytes.
- Published in:
- Immunity, Inflammation & Disease, 2025, v. 13, n. 1, p. 1, doi. 10.1002/iid3.70133
- By:
- Publication type:
- Article
A20 as a Potential Therapeutic Target for COVID‐19.
- Published in:
- Immunity, Inflammation & Disease, 2025, v. 13, n. 1, p. 1, doi. 10.1002/iid3.70127
- By:
- Publication type:
- Article
Structural biology of SARS-CoV-2 leader protein (nsp1).
- Published in:
- Crystallography Reviews, 2024, v. 30, n. 2, p. 118, doi. 10.1080/0889311X.2024.2325352
- By:
- Publication type:
- Article
Hemophagocytic lymphohistiocytosis post chimeric antigen receptor T cell therapies.
- Published in:
- Expert Review of Clinical Immunology, 2025, v. 21, n. 3, p. 277, doi. 10.1080/1744666X.2024.2444673
- By:
- Publication type:
- Article
Practical insights into bispecific antibody therapy in multiple myeloma.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 12, p. 1209, doi. 10.1080/14737140.2024.2445145
- By:
- Publication type:
- Article
First-in-human clinical trial results with ABBV-184, a first-in-class T-cell receptor/anti-CD3 bispecific protein, in adults with previously treated AML or NSCLC.
- Published in:
- Expert Review of Anticancer Therapy, 2024, v. 24, n. 9, p. 893, doi. 10.1080/14737140.2024.2373888
- By:
- Publication type:
- Article
Practical management of adverse events in patients receiving tarlatamab, a delta‐like ligand 3–targeted bispecific T‐cell engager immunotherapy, for previously treated small cell lung cancer.
- Published in:
- Cancer (0008543X), 2025, v. 131, n. 3, p. 1, doi. 10.1002/cncr.35738
- By:
- Publication type:
- Article
A Novel Step‐Up Dosage Regimen for Enhancing the Benefit‐to‐Risk Ratio of Mosunetuzumab in Relapsed or Refractory Follicular Lymphoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2025, v. 117, n. 2, p. 465, doi. 10.1002/cpt.3445
- By:
- Publication type:
- Article
Cassia alata butanol fraction anti-inflammatory effect on early expression of NFκB and cytokines in DENV-1 infected PBMCs.
- Published in:
- Journal of Applied Pharmaceutical Science, 2025, v. 15, n. 3, p. 143, doi. 10.7324/JAPS.2025.202697
- By:
- Publication type:
- Article
Cardiotoxicity and peri‐operative considerations in immune checkpoint inhibitor and chimeric antigen receptor T‐cell therapy: a narrative review.
- Published in:
- Anaesthesia, 2025, v. 80, n. S2, p. 25, doi. 10.1111/anae.16493
- By:
- Publication type:
- Article
Dissecting the COVID‐19 Immune Response: Unraveling the Pathways of Innate Sensing and Response to SARS‐CoV‐2 Structural Proteins.
- Published in:
- Journal of Molecular Recognition, 2025, v. 38, n. 2, p. 1, doi. 10.1002/jmr.70002
- By:
- Publication type:
- Article
Extracellular vesicle-bound S100A8/A9 is differentially expressed in septic shock and prompts acute lung injury.
- Published in:
- Respiratory Research, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s12931-025-03181-1
- By:
- Publication type:
- Article
CAR‐T Cell Manufacturing for Hematological and Solid Tumors: From the Preclinical to Clinical Point of View.
- Published in:
- Cancer Medicine, 2025, v. 14, n. 5, p. 1, doi. 10.1002/cam4.70726
- By:
- Publication type:
- Article
CAR‐T cells in the treatment of multiple myeloma: an encouraging cell therapy.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1499590
- By:
- Publication type:
- Article
Combined autologous hematopoietic stem cell transplantation and CD19 CAR T-cell therapy for relapsed/refractory diffuse large B-cell lymphoma with TP53 mutation: A case report.
- Published in:
- SAGE Open Medical Case Reports, 2025, p. 1, doi. 10.1177/2050313X241306236
- By:
- Publication type:
- Article
EDITORIAL.
- Published in:
- Oral & Maxillofacial Pathology Journal, 2024, v. 15, n. 2, p. iv
- By:
- Publication type:
- Article
In-depth analysis of the safety of CAR-T cell therapy for solid tumors.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1548979
- By:
- Publication type:
- Article
Implementation of chimeric antigen receptor (CAR) T-cell therapy in the NHS: prospects, promises and pitfalls.
- Published in:
- British Journal of Nursing, 2025, v. 34, n. 5, p. S20, doi. 10.12968/bjon.2024.0056
- By:
- Publication type:
- Article
Bispecific Antibodies.
- Published in:
- ONS Voice, 2025, p. N.PAG
- By:
- Publication type:
- Article
Influence of CAR T-cell therapy associated complications.
- Published in:
- Frontiers in Oncology, 2025, p. 1, doi. 10.3389/fonc.2025.1494986
- By:
- Publication type:
- Article
Feeder-cell-free system for ex vivo production of natural killer cells from cord blood hematopoietic stem and progenitor cells.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1531736
- By:
- Publication type:
- Article
Comparative evaluation of different treatment regimens of a tertiary care hospital -- A retrospective study for COVID-19 Patients.
- Published in:
- European Journal of Cardiovascular Medicine, 2024, v. 14, n. 6, p. 572
- By:
- Publication type:
- Article
Ciltacabtagene Autoleucel for the Treatment of Relapsed/Refractory Multiple Myeloma: Efficacy, Safety, and Place in Therapy.
- Published in:
- Cancer Management & Research, 2025, v. 17, p. 357, doi. 10.2147/CMAR.S510408
- By:
- Publication type:
- Article
Progress on diagnosis and treatment of multisystem inflammatory syndrome in children.
- Published in:
- Frontiers in Immunology, 2025, p. 1, doi. 10.3389/fimmu.2025.1551122
- By:
- Publication type:
- Article
Pharmacovigilance analysis of polatuzumab plus bendamustine and rituximab treatment protocol: identifying comprehensive safety signals using FDA database.
- Published in:
- Frontiers in Pharmacology, 2025, p. 1, doi. 10.3389/fphar.2025.1459067
- By:
- Publication type:
- Article
Dexamethasone for the management of CRS Related to teclistamab in patients with relapsed/refractory multiple myeloma.
- Published in:
- Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01222-y
- By:
- Publication type:
- Article
Investigating DNA damage caused by COVID-19 and influenza in post COVID-19.
- Published in:
- Mammalian Genome, 2025, v. 36, n. 1, p. 200, doi. 10.1007/s00335-024-10082-z
- By:
- Publication type:
- Article
Optimizing Real-World Outcomes in High-Risk Relapsed/Refractory (r/r) DLBCL with CAR T Cell Therapy: A Vodcast and Case Example.
- Published in:
- Oncology & Therapy, 2025, v. 13, n. 1, p. 11, doi. 10.1007/s40487-024-00319-x
- By:
- Publication type:
- Article
Exploring genetic loci linked to COVID-19 severity and immune response through multi-trait GWAS analyses.
- Published in:
- Frontiers in Genetics, 2025, p. 1, doi. 10.3389/fgene.2025.1502839
- By:
- Publication type:
- Article
Targeting GPRC5D With Talquetamab: A New Frontier in Bispecific Antibody Therapy for Relapsed/Refractory Multiple Myeloma.
- Published in:
- Annals of Pharmacotherapy, 2025, v. 59, n. 4, p. 350, doi. 10.1177/10600280241271192
- By:
- Publication type:
- Article
CAR-NK cell therapy: latest updates from the 2024 ASH annual meeting.
- Published in:
- Journal of Hematology & Oncology, 2025, v. 18, n. 1, p. 1, doi. 10.1186/s13045-025-01677-3
- By:
- Publication type:
- Article
The Development and Application of Bispecific Antibodies in B-Cell Non-Hodgkin Lymphoma.
- Published in:
- Journal of Personalized Medicine, 2025, v. 15, n. 2, p. 51, doi. 10.3390/jpm15020051
- By:
- Publication type:
- Article
Invasive Fungal Disease After Chimeric Antigen Receptor-T Immunotherapy in Adult and Pediatric Patients.
- Published in:
- Pathogens, 2025, v. 14, n. 2, p. 170, doi. 10.3390/pathogens14020170
- By:
- Publication type:
- Article
Clinical and Proteomic Insights into a Cytokine Release Syndrome Triggered by Tebentafusp in a Metastatic Uveal Melanoma Patient: Case Report.
- Published in:
- Journal of Clinical Medicine, 2025, v. 14, n. 4, p. 1333, doi. 10.3390/jcm14041333
- By:
- Publication type:
- Article
Recent Trends in Nanoantioxidants.
- Published in:
- Antioxidants, 2025, v. 14, n. 2, p. 207, doi. 10.3390/antiox14020207
- By:
- Publication type:
- Article
Bispecific antibody toxicities.
- Published in:
- Canadian Medical Association Journal (CMAJ), 2025, v. 197, n. 7, p. E190, doi. 10.1503/cmaj.241384
- By:
- Publication type:
- Article
Insight into the Life Cycle of Enterovirus-A71.
- Published in:
- Viruses (1999-4915), 2025, v. 17, n. 2, p. 181, doi. 10.3390/v17020181
- By:
- Publication type:
- Article
A Reversible Chemogenetic Switch for Chimeric Antigen Receptor T Cells**.
- Published in:
- Angewandte Chemie, 2022, v. 134, n. 10, p. 1, doi. 10.1002/ange.202109550
- By:
- Publication type:
- Article
Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients.
- Published in:
- Clinical & Experimental Nephrology, 2022, v. 26, n. 1, p. 75, doi. 10.1007/s10157-021-02126-4
- By:
- Publication type:
- Article
Population-level interest in anti-rheumatic drugs in the COVID-19 era: insights from Google Trends.
- Published in:
- Clinical Rheumatology, 2021, v. 40, n. 5, p. 2047, doi. 10.1007/s10067-020-05490-w
- By:
- Publication type:
- Article
Tracking awareness for Kawasaki disease in children related to the COVID-19 pandemic.
- Published in:
- 2021
- By:
- Publication type:
- Letter
High levels of anti-SSA/Ro antibodies in COVID-19 patients with severe respiratory failure: a case-based review: High levels of anti-SSA/Ro antibodies in COVID-19.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 11, p. 3171, doi. 10.1007/s10067-020-05359-y
- By:
- Publication type:
- Article
A complex COVID-19 case with rheumatoid arthritis treated with tocilizumab.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 9, p. 2797, doi. 10.1007/s10067-020-05234-w
- By:
- Publication type:
- Article
The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2085, doi. 10.1007/s10067-020-05190-5
- By:
- Publication type:
- Article
Treatment algorithm for COVID-19: a multidisciplinary point of view.
- Published in:
- Clinical Rheumatology, 2020, v. 39, n. 7, p. 2077, doi. 10.1007/s10067-020-05179-0
- By:
- Publication type:
- Article
Pan-selectin inhibitors as potential therapeutics for COVID-19 treatment: in silico screening study.
- Published in:
- Glycobiology, 2021, v. 31, n. 8, p. 975, doi. 10.1093/glycob/cwab021
- By:
- Publication type:
- Article
Comparative Evaluation of Systemic Immune Indexes in Infants Born to COVID-19 PCR Positive and Negative Mothers - Can Neonatal Effects Be Predicted?
- Published in:
- Namık Kemal Tıp Dergisi, 2022, v. 10, n. 2, p. 169, doi. 10.4274/nkmj.galenos.2022.59672
- By:
- Publication type:
- Article